Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-18

FDA Approved: METHIMAZOLE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Methimazole submitted by Chartwell RX, LLC (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methimazole (Methimazole)

Snippet

SUPPL AP for METHIMAZOLE (METHIMAZOLE)